Keywords: Human Genome Sciences, Takeover offer deadline, GlaxoSmithKline

Human Genome Sciences sets July 16 deadline for takeover bids

Article | 18 June 2012

Print This

In the latest update on UK pharma giant GlaxoSmithKline’s (LSE: GSK) hostile takeover attempts for Human Genome Sciences ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in